1)Yannuzzi LA:Central serous chorioretinopathy:a personal perspective. Am J Ophthalmol 149:361-363, 2010
2)Silva RM, Ruiz-Moreno JM, Murta JN et al:Photodynamic therapy for chronic central serous chorioretinopathy. Retina 33:309-315, 2013
3)Kang NH, Kim YK:Change in subfoveal choroidal thickness in central serous chorioretinopathy following spontaneous resolution and low-fluence photodynamic therapy. Eye 27:387-391, 2013
4)Reibaldi M, Zagari M, Boscia F et al:Standard-fluence versus low-fluence photodynamic therapy in chronic central serous chorioretinopathy:a nonrandomized clinical trial. Am J Ophthalmol 149:307-315, 2010
5)Goto S, Ueno C, Nishida K et al:Reduced-fluence photodynamic therapy for subfoveal serous pigment epithelial detachment with choroidal vascular hyperpermeability. Am J Ophthalmol 154:865-871, 2012
6)Ohkuma Y, Watanabe A, Tsuneoka H et al:One-year results of reduced fluence photodynamic therapy for central serous chorioretinopathy:the outer nuclear layer thickness is associated with visual prognosis. Graefes Arch Clin Exp Ophthalmol 251:1909-1917, 2013
7)羽生田直人・佐藤 拓・岸 章治・他:レーザー光凝固術後に脈絡膜新生血管を発生した中心性漿液性網脈絡膜症の特徴.眼紀 58:210-218,2007
8)竹田宗泰:脈絡膜新生血管の臨床的研究.その1.光凝固後に発生した脈絡膜新生血管.眼紀 33:24-34,1982
9)板垣 隆・大熊 鉱・加藤直子・他:網膜下新生血管に関する実験的研究.日眼会誌 89:600-610,1985
10)Zhang H, Sonoda KH, Ishibashi T et al:Choroidal neovascularization and subretinal fibrosis. Ophthalmology 95:925-929, 1988
11)Ishibashi T, Miller H, Ryan SJ et al:Morphologic observations on experimental subretinal neovascularization in the monkey. Invest Ophthalmol Vis Sci 28:1116-1130, 1987
12)Fung AT, Yannuzzi LA, Freund KB:Type 1(sub-retinal pigment epithelial)neovascularization in central serous chorioretinopathy masquerading as neovascular age-related macular degeneration. Retina 32:1829-1837, 2012
13)Warrow DJ, Hoang QV, Freund KB:Pachychoroid pigment epitheliopathy. Retina 33:1659-1672, 2013
14)Maruko I, Iida T, Spaide RF et al:Subfoveal choroidal thickness after treatment of central serous chorioretinopathy. Ophthalmology 117:1792-1799, 2010